These findings implicate the main genetic risk factor for MS, HLA‐DRB1*15, in relationships relevant to disease progression, and provide evidence of disease‐related changes to inhibitory synapses that are relevant to cortical neuronal survival. The gene discussed is HLA-DRB1; the disease is myeloid sarcoma.